CELCUITY INC. (CELC) Debt Components
- 2026-06-30: Convertible Notes PayableUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2026-06-30: Convertible Notes PayableUSD (m); Long-term DebtUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2026-03-31: Convertible Notes PayableUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2026-03-31: Convertible Notes PayableUSD $130.00M; Long-term DebtUSD $137.87M; Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD $44.01M.
CELCUITY INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable USD | Long-term Debt USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Interest Rate During Period pure | Debt Instrument, Convertible, Conversion Ratio pure | Debt Instrument, Unamortized Discount USD | Debt Instrument, Unamortized Discount (Premium), Net USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Notes Payable, Fair Value Disclosure USD | Short-term Debt USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Debt Instrument, Unamortized Discount, Current USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal Remainder of Fiscal Year USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 12.70% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-06-30 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 275.00% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $130.00M | $137.87M | (m) | $44.01M | $93.86M | 12.70% | (m) | (m) | $7.92M | (m) | $2.09M | $167.80M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $130.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $8.40M | (m) | $2.62M | $160.20M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $137.55M | (m) | $43.90M | $93.65M | 12.70% | (m) | (m) | (m) | $2.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $130.00M | $137.22M | (m) | $43.79M | $93.43M | (m) | (m) | (m) | $8.90M | $2.25M | $3.15M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 12.30% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $100.00M | $105.59M | $30.77M | $52.74M | $22.08M | (m) | (m) | (m) | $5.12M | (m) | $1.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | 12.30% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $100.00M | $105.34M | $30.69M | $52.61M | $22.04M | (m) | (m) | (m) | $5.44M | (m) | $1.37M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $100.00M | (m) | (m) | (m) | (m) | 12.30% | (m) | (m) | $5.75M | $2.44M | $1.61M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $105.09M | $30.62M | $52.48M | $21.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $100.00M | $104.84M | $30.54M | $52.35M | $21.95M | (m) | (m) | (m) | $6.06M | (m) | $1.86M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $100.00M | $104.59M | $30.46M | $52.22M | $21.91M | (m) | (m) | (m) | $6.30M | (m) | $2.09M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $35.00M | $38.03M | $14.26M | $19.02M | $4.75M | (m) | (m) | (m) | $45.02K | (m) | $419.92K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $35.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $49.44K | (m) | $480.81K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $37.57M | $14.09M | $18.78M | $4.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $35.00M | $37.10M | $13.91M | $18.55M | $4.64M | (m) | (m) | (m) | $53.67K | (m) | $540.39K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $35.00M | $36.64M | $13.74M | $18.32M | $4.58M | (m) | (m) | (m) | $57.68K | (m) | $598.11K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $35.00M | $36.19M | $13.57M | $18.10M | $4.52M | (m) | (m) | (m) | $61.44K | (m) | $653.55K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $35.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $65.00K | (m) | $707.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $35.76M | (m) | $13.41M | $17.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.47M | (m) | (m) | (m) |
| 2022-09-30 | $15.00M | $16.29M | $5.85M | $7.81M | $2.63M | (m) | (m) | (m) | $792.05K | (m) | $481.30K | (m) | (m) | (m) | (m) | $652.06K | (m) |
| 2022-06-30 | $15.00M | $16.18M | $5.81M | $7.75M | $2.61M | (m) | (m) | (m) | $850.18K | (m) | $319.36K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $15.00M | $16.08M | $5.78M | $7.70M | $2.60M | (m) | (m) | (m) | $907.59K | (m) | $346.48K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $962.50K | (m) | $386.58K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $15.98M | (m) | $5.74M | $7.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.59M | $652.06K | (m) |
| 2021-09-30 | $15.00M | $15.87M | (m) | $5.70M | $7.60M | (m) | (m) | (m) | $1.02M | (m) | $-426.88K | (m) | (m) | (m) | $2.57M | $652.06K | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $652.06K | (m) |
| 2021-06-30 | $15.00M | $15.77M | (m) | (m) | $5.66M | (m) | (m) | (m) | $1.07M | (m) | $466.48K | (m) | $5.83K | $7.55M | $2.56M | (m) | $3.63K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |